Illustration(s) pertain to the topic addressed in this publication, not the specific research or data presented in the publication

Who We Are / Areas of Expertise

Janine Jason, M.D.

Pediatrics, Board-certified
Immunology/Allergy, Board-eligible

Clinical and Research Expertise in Infectious Diseases
Trained in the Epidemiology Intelligence Service (EIS) Program, Centers for Disease Control & Prevention

Dr. Jason has over 35 years of research experience, clinical expertise and numerous peer-reviewed publications, including the areas of:

Epidemiology: medical cost analyses, disease incidence and prevalence estimations, medical cost-benefit calculations; design, analysis, and interpretation of epidemiologic studies, data, and outbreaks; infectious disease epidemiology; and epidemiologic techniques
Pediatrics: child health, infant feeding, breast feeding, infant mortality, child abuse, child homicide, parenting, and caring for premature infants
Infectious diseases: HIV/AIDS, hepatitis B (HBV), hepatitis C (HCV), hemophilia-associated AIDS, blood product-related infections, blood product safety, bloodborne pathogens, accidental needlestick injuries, and pediatric infections
Therapy of infectious diseases: reviewing clinical research articles and educating investors and corporate executives about the associated findings, including those related to hepatitis C (HCV), human immunodeficiency virus (HIV) infections and treatment, and immunotherapies
Immunology: immunodeficiency, opportunistic infections, cytokines, T-cell immunology, immunologic laboratory techniques, immunotherapies, and flow cytometry
Public Health: HIV, health communications, parenting, and assessments of the incidence, prevalence, and healthcare costs associated with various diseases
Translating basic research: reviewing and interpreting basic immunologic and microbiologic research articles and educating investors and corporate executives about the practical implcations of the associated findings
Medical legal expert consulting: on select cases only
Recent research topics: Dr. Jason’s recent projects have included determining the incidence, characteristics, and associated healthcare costs of community-acquired accidental needlestick injuries, evaluating the risks of transmission of bloodborne pathogens (including HIV, HBV, and HCV) in health care, occupational, and community settings, and advising State legislators of her findings; epidemiologic studies of Cronobacter sakazakii (formerly Enterobacter sakazakii) infections in children; and determining the incidence, characteristics, and associated healthcare costs of polycystic ovary syndrome (PCOS).  Dr. Jason has recently authored peer-reviewed papers on these topics. She has also assisted in medical outbreaks and legal cases involving various: infections, including HIV, HCV, herpes viruses, coxsackie viruses, cytomegalovirus, Salmonella, toxoplasmosis, tubercular and no-tubercular mycobacteria, Streptococcus, and methicillin-sensitive and resistant Staphylococcus aureus (MSSA and MRSA); syndromes, including toxic shock syndrome, necrotizing fasciitis, and Kawasaki disease  infections; disease complications, including of drug therapies, transplantation, and chronic disorders associated with secondary immunodeficiency and infections.

williamjarvisWilliam R. Jarvis, M.D.

Pediatrics, Board-certified
Pediatric Infectious Diseases, Board-eligible

Dr. Jarvis has over 40 years of clinical expertise and over 400 peer-reviewed publications concerning:

  • infection control,
  • healthcare epidemiology,
  • outbreak investigations,
  • pediatric infectious diseases,
  • infectious diseases,
  • surgical site infections,
  • bloodstream infections,
  • pneumonia,
  • urinary tract infections,
  • all device -associated infections,
  • cost-benefit of infection control,
  • antimicrobial resistance (particularly methicillin-resistant Staphylococcus aureus [MRSA] and vancomycin-resistant enterococci [VRE] or S. aureus [including VISA or VRSA]),
  • prevention and control of Mycobacterium tuberculosis transmission to patients and healthcare workers [national and international],
  • infection control in developing countries,
  • guidelines for prevention and control of infections in healthcare settings,
  • patient safety,
  • healthcare-associated infection surveillance,
  • fungal infections,
  • adverse events associated with healthcare delivery,
  • and epidemiologic methods.